Knopp Biosciences
Latest round
- Series C
Last raised
- Nov 2020
Total raised
- $39M
Investors
- 4
About Knopp Biosciences
Founded in 2005 and headquartered in Pittsburgh, US, Knopp Biosciences LLC specializes in the development of therapies targeting challenging health conditions. The company has undergone strategic pivots focusing on its lead product, dexpramipexole, after collaborations with other firms.Knopp Biosciences concentrates on innovative therapies for immunological and neurological diseases. Its primary product, dexpramipexole, is an oral small molecule under development for eosinophilic asthma, developed in partnership with Areteia Therapeutics, Inc. Additionally, the company's Kv7 platform, designed for epilepsy and other hyperexcitability disorders, has been acquired by Biohaven Pharmaceuticals for further development.S.Revenue for Knopp Biosciences primarily arises from strategic partnerships with pharmaceutical firms and management of equity securities alongside future product royalties. Collaborations, such as with Areteia Therapeutics and Biohaven Pharmaceuticals, allow for milestone payments and royalties based on successful product commercialization. Furthermore, the company is set to launch first-in-human studies of KB-3061 in 2021.
Who invested in Knopp Biosciences
4 investors across 5 rounds
See all investors in Knopp Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Knopp Biosciences
Who invested in Knopp Biosciences?
Knopp Biosciences has 4 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Knopp Biosciences raised?
Knopp Biosciences has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Knopp Biosciences last raise money?
Knopp Biosciences's most recent round on record is a Series C, in Nov 2020.
What does Knopp Biosciences do?
Founded in 2005 and headquartered in Pittsburgh, US, Knopp Biosciences LLC specializes in the development of therapies targeting challenging health conditions.
Where is Knopp Biosciences headquartered?
Knopp Biosciences is headquartered in Pittsburgh, US.
Which VCs invest in companies like Knopp Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Knopp Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Knopp Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.